Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jul;58(7):673-84.
doi: 10.1136/jcp.2002.003954.

Molecular pathology of prostate cancer

Affiliations
Review

Molecular pathology of prostate cancer

C Hughes et al. J Clin Pathol. 2005 Jul.

Abstract

The molecular pathology of prostate cancer is complex; not only are multiple genes involved in its pathogenesis, but additional environmental factors such as diet and inflammation are also involved. The exhaustive research into prostate cancer to date has demonstrated a complex interaction of multiple genes and environmental factors, some of which may be more important in individual prostate cancer cases. This is an exciting era, with the emergence of new investigative tools such as DNA microarray technology and the application of the field of proteomics to the study of human cancers. Knowledge of genetic changes underlying the initiation, development, and progression of prostate cancer is accumulating rapidly. With increasing knowledge, it may be possible to distinguish indolent from aggressive prostate tumours by molecular fingerprinting. This review discusses the most consistently reported molecular pathological findings in hereditary and sporadic prostate cancer, together with new concepts and technologies.

PubMed Disclaimer

References

    1. Sanchez-Chapado M, Olmedilla G , Cabeza M , et al. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 2003;3:238-47. - PubMed
    1. Toms J. Cancer incidence, survival and mortality in the UK and EU. UK: Cancer Stats Monograph 2004. London: Cancer Research UK, 2004.
    1. Carter B, Bova G , Beaty T , et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797-802. - PubMed
    1. DeMarzo AM, Nelson WG, Isaacs WB, et al. Pathological and molecular aspects of prostate cancer. Lancet 2003;361:955-64. - PubMed
    1. Rebbeck TR, Walker AH, Zeigler-Johnson C , et al. Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 2000;61:1014-19. - PMC - PubMed

Publication types